Weiss Multi-Strategy Advisers’s PhenomeX Inc. Common Stock CELL Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-22,907	Closed	-$416K	–	823
2021 Q4	$416K	Sell	22,907 -93	-0.4%	-$2.01K	0.01%	562
2021 Q3	$450K	Buy	23,000 +1,000	+5%	+$38K	0.01%	569
2021 Q2	$986K	Sell	22,000 -5,064	-19%	-$235K	0.02%	492
2021 Q1	$1.36M	Buy	27,064 +5,905	+28%	+$403K	0.03%	452
2020 Q4	$1.89M	Buy	21,159 +5,820	+38%	+$490K	0.04%	429
2020 Q3	$1.17M	Buy	+15,339	New	+$974K	0.03%	410

Other funds holding CELL

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CELL Position: Q1 2022 in Review

Weiss Multi-Strategy Advisers sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 22,907 shares — an estimated $416K sold.

Weiss Multi-Strategy Advisers first reported a position in CELL in Q3 2020 and held it in 6 quarters. The position peaked at $1.89M in Q4 2020. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

Weiss Multi-Strategy Advisers reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 22,907 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $416K.
Weiss Multi-Strategy Advisers first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's PhenomeX Inc. Common Stock position peaked at $1.89M in Q4 2020.
130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.